版本:
中国

BRIEF-RXi Pharmaceuticals enters into exclusive option agreement to acquire Mirimmune Inc

Oct 12 RXi Pharmaceuticals Corp :

* RXi Pharmaceuticals enters into exclusive option agreement to acquire Mirimmune Inc

* RXi Pharmaceuticals Corp - can exercise option to acquire Mirimmune on terms set forth in option agreement at any time prior to April 5, 2017

* RXi Pharmaceuticals Corp - deal for number of shares equal to 19.99% of then outstanding shares of common stock of RXi

* RXi Pharmaceuticals Corp - entered into an option agreement to acquire all outstanding capital stock of Mirimmune Inc

* RXi Pharmaceuticals Corp - deal also provides for additional potential consideration contingent on Mirimmune reaching certain milestones Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐